Senzar Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-35,700
Closed -$2.51M 3
2018
Q2
$2.51M Sell
35,700
-343,155
-91% -$24.7M 7.23% 5
2018
Q1
$26.5M Buy
+378,855
New +$26.2M 8.36% 1

Other funds holding AZN

Senzar Asset Management's AZN Position: Q3 2018 in Review

Senzar Asset Management sold out of AstraZeneca (AZN) in Q3 2018, closing a stake of 35,700 shares — an estimated $2.51M sold.

Senzar Asset Management first reported a position in AZN in Q1 2018 and held it in 2 quarters. The position peaked at $26.5M in Q1 2018. 544 funds tracked by Wall St. Rank hold AZN as of Q3 2018.

  • Senzar Asset Management reported no remaining AstraZeneca position as of Q3 2018 after selling out during the quarter.
  • Senzar Asset Management sold 35,700 AstraZeneca shares in Q3 2018, an estimated $2.51M.
  • Senzar Asset Management first reported a position in AstraZeneca in Q1 2018 and held it in 2 quarters.
  • Senzar Asset Management's AstraZeneca position peaked at $26.5M in Q1 2018.
  • 544 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.